Millions of Americans suffer from chronic pain or neuroinflammatory diseases like Alzheimer’s and Parkinson’s Disease. Most available medications for pain are either not effective enough or have harmful side effects. In the case of neuroinflammatory diseases, existing drugs tend to focus only on symptomatic relief without modifying disease progression. Chronic pain and neuroinflammatory diseases are increasing, driving a pressing need for novel drugs that are both safe and effective.
Pain
Pain is not just a physical symptom: it also affects the quality of life of patients and their loved ones. Safe, non-addictive and effective oral treatments are needed.
Neuroinflammation
Patients with Alzheimer’s Disease, Parkinson’s Disease, and other neuroinflammatory diseases need novel disease-modifying therapies.
Our Pipeline
These programs are investigating therapeutic approaches that have not yet been approved by health authorities. There is no assurance that any of these programs will lead to approval by a regulatory agency. For information on our active and completed clinical trials, consult clinicaltrials.gov.
